SA PRO
Free Account
ALX Oncology Holdings Inc.ALXONASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 86% recommend buying.

Consensus Rating
Buy
7 analysts·Limited coverage
86%
Rating Distribution
Strong Buy
00%
Buy
686%
Hold
114%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 1043% higher.

Bear Case
$1.50
-20%
Consensus
$21.38
+1043%
Bull Case
$38.00
+1932%
Price Range7 analysts
Low
Consensus
High
$1.50
$38.00
Current Target
Current Price
$1.87
Upside to Target
$19.51

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Mar 7, 2025Stifel Nicolaus
ALX Oncology price target lowered to $1.50 from $3 at Stifel
Target:$1.50
+41.5%from $1.06
Jun 10, 2024UBS
UBS Reiterates Buy Rating on ALX Oncology (ALXO)
Target:$25.00
+183.3%from $8.82
Jun 3, 2024Raymond James
Piper Sandler Reiterates Overweight Rating on ALX Oncology (ALXO)
Target:$21.00
+130.8%from $9.10
Apr 10, 2024Stifel Nicolaus
Stifel on ALX Oncology (ALXO): 'our Hold thesis is based on the lack of development strategy clarity in these opportunities'
Target:$14.00
+18.1%from $11.85
Aug 9, 2022Credit Suisse
Credit Suisse Maintains Outperform on ALX Oncology Holdings, Lowers Price Target to $38
Target:$38.00
+222.9%from $11.77
Jun 13, 2022Stifel Nicolaus
ALX Oncology (ALXO) Stock Price: $16 Target And Buy Rating
Target:$16.00
+135.8%from $6.79

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance